
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Pharmaceutical Amorphous Solid Dispersions
About this book
Providing a roadmap from early to late stages of drug development, this book overviews amorphous solid dispersion technology – a leading platform to deliver poorly water soluble drugs, a major hurdle in today's pharmaceutical industry. •Helps readers understand amorphous solid dispersions and apply techniques to particular pharmaceutical systems
•Covers physical and chemical properties, screening, scale-up, formulation, drug product manufacture, intellectual property, and regulatory considerations
•Has an appendix with structure and property information for polymers commonly used in drug development and with marketed drugs developed using the amorphous sold dispersion approach
•Addresses global regulatory issues including USA regulations, ICH guidelines, and patent concerns around the world
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Title Page
- Copyright
- Dedication
- Preface
- Contributors
- Chapter 1: Introduction to Amorphous Solid Dispersions
- Chapter 2: Polymers and Surfactants
- Chapter 3: Amorphous Solid Dispersion Screening
- Chapter 4: Solid-State Characterization of Amorphous Dispersions
- Chapter 5: Physical Stability and Crystallization Inhibition
- Chapter 6: Solubility and Dissolution Considerations for Amorphous Solid Dispersions
- Chapter 7: Translational Development of Amorphous Dispersions
- Chapter 8: Preclinical and Clinical Studies
- Chapter 9: Spray Drying and Scale-Up
- Chapter 10: Hot Melt Extrusion of Amorphous Solid Dispersions
- Chapter 11: Formulation Development of Amorphous Dispersions
- Chapter 12: Scientific and Regulatory Considerations in Product Development*
- Chapter 13: Patenting Amorphous Solid Dispersions of Pharmaceuticals*
- Chapter 14: Monographs on Polymers and Surfactants
- Appendix A
- Appendix B: Marketed Products
- Index
- EULA